BridgeBio Pharma Inc. (NASDAQ:BBIO) is a biopharmaceutical company that focuses on developing innovative therapies for genetic diseases. The company’s research and development platform uses...
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish...
Key takeaways The fund outperformed its benchmark Strong stock selection in pharmaceuticals, health care equipment and biotechnology contributed the most to relative performance during...